Work

A Phase II Clinical Trial of Interleukin-2 and Lymphokine-Activated Killer Cells in Advanced Colorectal Carcinoma

Year: 1994

Type: article

Study design: Clinical Trial

Source: Journal of Immunotherapy

DOI: 10.1097/00002371-199401000-00010

Authors: Michael J. Hawkins, Michael B. Atkins, Janice P. Dutcher, Richard I. Fisher, Geoffrey R. Weiss, Kim A. Margolin, Anthony A. Rayner, Mario Sznol, David R. Parkinson, Elizabeth Paietta, Ellen R. Gaynor, David H. Boldt, James H. Doroshow, Frederick R. Aronson

Institutions: National Institutes of Health, National Cancer Institute, Tufts Medical Center, Albert Einstein College of Medicine, Yeshiva University, Loyola University Medical Center, Loyola University Chicago, The University of Texas at San Antonio, City Of Hope National Medical Center, City of Hope, University of California, San Francisco

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1105070095, G1505869703, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES, G2197280113, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES, CLINICAL TRIALS OF ACTIVATED HUMAN LEUKOCYTES

OpenAlex ID: W1966320652

FWCI: 0.984

Cites:

Cited by: 33

Related to: 10